GoodRx Holdings, Inc.GDRXNASDAQ
Loading
R&D Expenses Over TimeStrong
Percentile Rank56
3Y CAGR-5.4%
5Y CAGR+14.4%
Studio
Year-over-Year Change

Research and development spending

3Y CAGR
-5.4%/yr
vs +34.4%/yr prior
5Y CAGR
+14.4%/yr
Recent deceleration
Acceleration
-39.8pp
Decelerating
Percentile
P56
Within normal range
vs 5Y Ago
2x
Strong expansion
Streak
3 yr
Consecutive declineStrong
PeriodValueYoY Change
TTM$121.03M-2.2%
2024$123.75M-8.9%
2023$135.84M-5.1%
2022$143.14M+13.7%
2021$125.86M+103.6%
2020$61.82M+111.0%
2019$29.30M-33.2%
2018$43.89M+281.7%
2017$11.50M+100.3%
2016$5.74M-